Cervical cancer screening and HPV vaccine outreach: screening pages, self-collection, the 2026 vaccine schedule dispute, recall texts and coverage

Cervical cancer screening outreach asks people who feel well to book a test that they may find awkward or put off for years, and HPV vaccine outreach asks parents to vaccinate a preteen against a virus they may not want to discuss. The program may be a primary care office that adds screening to its recall list, an OB-GYN or women’s health practice, a community health center, a school-based health center, a pediatric practice, a sexual health clinic, or a health fair that offers screening. This guide covers how to build a screening page on federal recommendations that are being updated, how to describe patient-collected samples without overstating what a test is approved for, how to word HPV vaccine pages while the 2026 federal childhood schedule is in court, how to word recall texts and result calls, and how free screening, coverage and partners meet the federal rules.

Eight related topics have their own guides and are not repeated here. Breast screening is covered in our guide to mammogram outreach and colon screening in our guide to colorectal cancer screening outreach. Women’s health practices are covered in our guide to OB-GYN practice marketing, and childhood vaccines in our guide to Vaccines for Children provider marketing. School clinics are covered in our guide to school-based health center marketing, sexual health services in our guide to sexual health clinic marketing, pop-up screening in our guide to health fair and screening event marketing, and community programs in our guide to community health center marketing.

What the federal sources say

The US Preventive Services Task Force (USPSTF), the Health Resources and Services Administration (HRSA), the CDC, the National Cancer Institute (NCI) and MedlinePlus from the National Library of Medicine publish the federal positions on cervical cancer screening and HPV vaccination. The points that shape an outreach program’s marketing:

• The USPSTF final recommendation Cervical Cancer: Screening (August 21, 2018) recommends screening every 3 years with cervical cytology (the Pap test) alone for women aged 21 to 29, and for women aged 30 to 65 screening every 3 years with cytology alone, every 5 years with high-risk HPV testing alone, or every 5 years with both together (cotesting), each a grade A recommendation. It recommends against screening women younger than 21, women older than 65 who have had adequate prior screening and are not otherwise at high risk, and women who have had a hysterectomy with removal of the cervix and no history of a high-grade precancerous lesion or cervical cancer. It says the recommendation applies to individuals with a cervix who have no symptoms, regardless of their sexual history or HPV vaccination status. The page is marked “Update in Progress”.
• The HRSA page Women’s Preventive Services Guidelines (last reviewed December 2025, read through an archived copy) says HRSA approved an updated cervical cancer screening guideline in December 2025, effective beginning with plan years starting in 2027. The update names primary HPV testing every 5 years as preferred for women aged 30 to 65, keeps cotesting every 5 years, keeps cytology alone every 3 years where HPV testing is not available, says patient-collected HPV testing is an appropriate method and should be offered as an option for women aged 30 to 65 at average risk, and lists the follow-up testing needed to complete the screening process. The same page lists patient navigation services for breast and cervical cancer screening.
• The CDC page Screening for Cervical Cancer (February 26, 2025, read through an archived copy) describes the Pap test and the HPV test, says cervical precancer may cause no pain or other symptoms, explains each type of result in plain words, and points people worried about cost to CDC’s National Breast and Cervical Cancer Early Detection Program for free or low-cost screening.
• The NCI page Cervical Cancer Screening (updated February 13, 2025) summarizes the USPSTF options, notes that a separate professional society guideline starts screening at age 25 with HPV testing, and tells readers they may have the option to self-collect the sample during their appointment.
• The CDC page HPV Vaccine (August 20, 2024, read through an archived copy) recommends HPV vaccination at ages 11 to 12, says it can start at age 9, recommends it for teens and young adults through age 26 who did not start or finish the series, and says vaccination is not recommended for everyone older than 26. The CDC page HPV Vaccination Considerations (July 9, 2024, read through an archived copy) says adults aged 27 through 45 who were not adequately vaccinated might decide to get the vaccine after a discussion with their clinician, and that the vaccine prevents new HPV infections but does not treat existing infections or diseases.

Two of these sources are changing. The USPSTF screening recommendation is eight years old and marked as an update in progress, and the HRSA update that names self-collection and primary HPV testing takes effect for plan years starting in 2027. Name each source and its date next to the interval it gives, say that a clinician confirms the right test and interval for each person, and check both sites at each review.

The federal childhood vaccine schedule is in dispute. The Congressional Research Service report The 2026 Childhood Immunization Schedule (June 11, 2026) says HHS released a revised childhood schedule in January 2026 that, among other changes, cut the recommended number of HPV vaccine doses from two to one, and that a federal district court stayed that schedule on March 16, 2026. The CRS Legal Sidebar CDC’s Updated Childhood Vaccine Schedule: Litigation and Potential Implications for Vaccine Injury Compensation Program (May 4, 2026) says the government appealed the stay to the First Circuit on April 29, 2026. The archived CDC schedule notes we read on October 30, 2026 still showed the 2025 schedule. We could not confirm from a primary source what has happened in the case since June 2026, so this guide gives no dose count for children. A practice should check the current CDC schedule, and ask counsel about the state of the case, before it writes a dose count on any page.

Two points shape the marketing. First, screening is for people without symptoms, and the test, the interval and the age to start or stop depend on the person’s age, history and the source the clinician follows; a page that names one interval for everyone will be wrong for someone. Second, a person who has had the HPV vaccine still needs screening: the USPSTF says vaccinated women should continue to be screened as recommended, so a vaccine page should not suggest that the vaccine replaces the test.

Screening pages and claims that need rewriting

Google’s search suggestions, which we checked on October 30, 2026, offer “cervical cancer screening age”, “cervical cancer screening guidelines”, “cervical cancer screening vs pap smear”, “cervical cancer screening how is it done” and “cervical cancer screening in spanish” to a person who types “cervical cancer screening”, “pap smear age”, “pap smear test” and “pap smear near me” after “pap smear”, “hpv vaccine schedule”, “hpv vaccine side effects”, “hpv vaccine age” and “hpv vaccine for boys” after “hpv vaccine”, and “hpv vaccine for adults over 30”, “hpv vaccine for adults over 45” and “hpv vaccine for adults cost” after “hpv vaccine for adults”. A screening page can answer each of those honestly: who the test is for and at what age, how a Pap test differs from an HPV test, how the sample is taken and whether the person can collect it, what each result means and what happens next, and what the test costs and who pays.

A page that holds up says that screening checks people without symptoms for changes before they become cancer, names the tests the practice offers, says a clinician helps each person choose the test and the interval from the federal recommendations, explains how long results take and who calls, and offers the page in the languages the practice’s patients speak. Use plain anatomical words, say who the clinician will be if the person prefers a woman clinician and the practice can offer one, and say that a chaperone is available if the practice offers one.

Phrases that need rewriting:

• “Every woman needs a Pap smear every year.” The USPSTF gives intervals of 3 or 5 years by age and test, and recommends against screening some groups. Name the source and its intervals, and say the clinician confirms the right one.
• “Got the HPV vaccine? You can skip your Pap.” The USPSTF says vaccinated women should continue to be screened as recommended. Remove it.
• “Test yourself at home, no clinic visit needed.” FDA approvals from May 2024 cover self-collection in a health care setting. Advertise home collection only for a test whose FDA-approved labeling covers it, and say what follow-up still needs a visit.
• “An abnormal Pap means cancer.” CDC says an abnormal result does not in itself mean cancer and that more tests are needed. Say a clinician explains each result and the next step.
• “The HPV vaccine prevents all cervical cancer.” CDC says the vaccine protects against the HPV types that cause the bulk of HPV cancers and that it does not treat existing infections. Quote CDC with the date, or remove it.
• “Our patients’ abnormal Pap rate is half the national rate.” Outcome numbers with no source. Remove them unless they are drawn from the practice’s own documented and reviewed records, with their date and limits stated.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. Quoting the federal sources as written, with each one named and dated, stays inside that standard; turning a federal statement into a promise to the reader does not.

Symptoms, urgent signs and 911 on every page and in every tool

Screening is for people without symptoms, so the page has to send people with symptoms elsewhere. The MedlinePlus page Cervical Cancer (last updated January 2, 2025) says cervical cancer may not cause symptoms when it first starts to grow, and lists vaginal bleeding that is not normal for the person, such as bleeding after sex or between periods, unusual vaginal discharge, and pelvic pain or pain during sex among the symptoms when it does. Put plain lines above the booking button and on flyers: if you have bleeding that is not normal for you, or new pelvic pain, call [phone] and ask for a visit; do not wait for a screening appointment. Call 911 for heavy bleeding or any medical emergency. Ask the practice’s clinicians to review each line before it goes live.

The same wording belongs in voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools, and on cards handed out at a screening event. A tool should hand any message about bleeding, pain or a symptom to a clinician or the on-call line, send any message about an emergency to the 911 line and alert staff, pass questions about results to a clinician, and never explain a Pap or HPV result itself. Our guides to the AI chatbot on a practice website and answering service versus AI receptionist cover how tools hand off these messages.

Self-collection: say what the approval covers

Self-collection lets a person take their own vaginal sample for an HPV test with a swab instead of a speculum exam. It can bring in people who have put off screening, and it is a strong outreach message, which is why it needs care. The FDA Roundup of May 17, 2024 says FDA expanded the instructions for use of HPV tests so a patient can self-collect a vaginal sample in a health care setting when the patient and the provider decide a clinician-collected cervical sample is not possible. Our check of the FDA premarket approval database on October 30, 2026 found later approvals, including one in April 2026 that expanded the settings in which self-collected samples are taken for one test. The HRSA update says patient-collected HPV testing should be offered as an option for women aged 30 to 65 at average risk from plan years starting in 2027.

Keep these points on a self-collection page:

• Say where the sample is taken, in the clinic or at home, exactly as the approved labeling of the test the practice uses allows, and confirm that labeling with the lab before the page goes live.
• Name the age group the practice offers it to and say a clinician decides whether it suits each person, as the federal sources tie it to age and average risk.
• Say that a positive result can need a follow-up visit, more tests or an exam, as the HRSA update lists the testing needed to complete the screening process.
• Do not call self-collection “painless”, “just as good for everyone” or a replacement for every visit. Say what it is and what follow-up may be needed.
• Name no test brand or lab in ads or on the page.

Explaining results without a diagnosis

The CDC screening page explains that a Pap result can be normal, unclear, abnormal or unsatisfactory, and an HPV result positive or negative. It says an unclear result is frequent and may be linked to pregnancy, menopause or an infection, that an abnormal result does not in itself mean cancer, that minor changes can go back to normal on their own, that more serious changes are called precancer and can be removed, and that a positive HPV result means a type linked to cervical cancer was found, not that the person has cancer now. It says results can take as long as three weeks.

A results page or a results text can set expectations without explaining anyone’s own result. Keep these points:

• Describe the result types in plain words, in the order CDC uses, and say a clinician explains each person’s own result and the next step.
• Say how and when the practice calls, and how long results can take. Never post, text or leave the result on voicemail.
• For an abnormal or positive result, name the next step the practice has arranged, such as a repeat test or a follow-up exam, and that a navigator or staff member helps book it if the practice offers navigation.
• Do not write that a normal result means the person “can’t get” cervical cancer. CDC says the chance in the next few years is very low and that future screening is still needed.

HPV vaccine pages while the schedule is in court

Vaccine pages draw the “hpv vaccine schedule”, “hpv vaccine age”, “hpv vaccine for boys” and “hpv vaccine side effects” searches. Answer each with the CDC wording and date, and keep the dose count off the page until the practice has checked the current CDC schedule and the state of the court case. For age, quote CDC: vaccination at ages 11 to 12, starting as early as 9, recommended through age 26 for those who did not start or finish, and for adults aged 27 through 45 a decision made with the clinician. For boys, say the CDC recommendation covers boys and girls, as the CDC page says all preteens need HPV vaccination. For side effects, quote the CDC list with its date, which leads with pain, redness or swelling in the arm, and send other questions to the clinician.

Keep these points on a vaccine page:

• Give no number of doses for children and teens unless the practice has checked it against the current CDC schedule on the day the page is written, and record that date in the page’s review notes.
• Do not write that the vaccine is required for school unless the practice has checked the rule; school vaccine requirements are set state by state.
• Do not name a vaccine brand in ads or on the page. If a parent asks which vaccine the practice uses, the clinician answers.
• Say that the vaccine works best before a person is exposed to the virus, as CDC says, without implying anything about a child’s behavior.
• Say that vaccinated people still need cervical cancer screening when they reach the screening age.
• Rules on whether a minor can consent to a vaccine without a parent are set state by state; ask counsel before a page or a school event says a teen can come in alone.
• Vaccines for Children eligibility and enrollment follow our guide to Vaccines for Children provider marketing.

Supplements offered for HPV or cervical health need the same care. The FDA Questions and Answers on Dietary Supplements (content current as of August 27, 2026) says FDA does not have the authority to approve dietary supplements before they are marketed. Name no product, make no claim that a supplement clears HPV, heals precancer or prevents cervical cancer, and follow our guide to selling supplements in a medical practice.

Recall texts, letters and reminders

Outreach programs reach people through recall lists: patients aged 21 to 65 with no screening on file within the interval the clinician set, patients with an abnormal or positive result who have not come back for follow-up, and preteens and teens who started the HPV vaccine series and are due for another dose. Under 45 CFR 164.501, a communication about the practice’s own treatment for an individual, such as a reminder to come in for a recommended screening, a follow-up test or the next vaccine dose, can fall outside the definition of marketing, while a message that promotes a third party’s product or service generally needs a signed authorization under 45 CFR 164.508.

The words in the message matter as much as the rule. A text, a postcard or a voicemail can be seen by a partner, a parent or a child. Keep these points:

• Name no test, no result and no body part in the message text. Write “[Practice name] has a recommended screening for you. Call [phone] or book online.” and give details only after the person signs in or calls.
• A follow-up reminder can say “Please call [phone] to schedule your follow-up visit.” without naming the result.
• A vaccine reminder for a teen goes to the contact the family chose, says “[Practice name]: a vaccine dose is due for your child. Call [phone] or book online.” and names no vaccine unless the family has agreed to more detail.
• Do not mention a Pap test, HPV or a colposcopy on an envelope, a postcard or a caller ID name, and do not leave a result on voicemail.
• Send messages in the language the patient chose, use the contact method they chose, and honor opt-out requests in every channel.
• Do not send recall lists, results or vaccine records to an ad platform to build an audience.

Our guides to text message appointment reminders and the patient recall system cover consent, timing and opt-outs.

Free screening, coverage and costs

Coverage pages draw the “hpv vaccine for adults cost” search and the cost questions behind “pap smear near me”. The Medicare.gov page Cervical and vaginal cancer screenings, checked on October 30, 2026, says Part B covers Pap tests and pelvic exams once every 24 months in general, once every 12 months for people at high risk or of child-bearing age with an abnormal Pap test in the past 36 months, and HPV tests as part of a Pap test once every 5 years for people aged 30 to 65 without HPV symptoms, and that the person pays nothing if the provider accepts assignment. Describe Medicare coverage in those terms, note that the HRSA update applies to health plans that must cover these preventive services from plan years starting in 2027, and say the practice checks coverage for each patient’s plan. The CDC screening page points uninsured and low-income people to CDC’s National Breast and Cervical Cancer Early Detection Program; link the CDC page rather than promising eligibility. Medicaid coverage is set state by state; our guides to marketing to Medicare patients and marketing to Medicaid patients cover the wider rules.

Follow-up tests and procedures after an abnormal result belong in the clinician and billing conversation, not in an ad. Do not write “free follow-up care” unless the practice has confirmed it for each person it reaches. Cash prices for a Pap test, an HPV test or a vaccine dose follow our guides to advertising cash prices and good faith estimates for self-pay patients.

A “free” screening day, a free vaccine dose, a gift card for finishing the series or a raffle at a school event follows 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere, and that the terms of the offer should be stated at the outset. Under 42 U.S.C. 1320a-7a(a)(5), civil penalties can apply to a person who offers or transfers remuneration to a Medicare or state health care program beneficiary that the person knows or should know is likely to influence the beneficiary to order or receive items or services from a particular provider, practitioner or supplier. Incentives for screening or for finishing the vaccine series need counsel’s review before they run, and a grant-funded program should also check its grant terms.

Partners, sponsors and referral payments

Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Rules on referral fees are also set state by state.

For a cervical cancer screening and HPV vaccine program, keep these points:

• Do not accept free staff, vaccine doses, event funding or marketing help from a vaccine maker, a test maker or a lab tied to the tests and vaccines the practice orders, without counsel’s review; our guide to Open Payments covers reported payments from manufacturers.
• Do not steer samples to one lab in exchange for anything of value.
• Do not pay a school, a community group, a place of worship, a venue, an outreach worker or a marketing company per person screened, vaccinated or referred without counsel’s review.
• Referral arrangements with gynecology practices for follow-up exams follow our guide to patient and physician referrals.

Privacy, pixels and ads

A visit to a Pap test page, a results question or a booking form says something about a person’s health and sexual health, and a vaccine booking for a teen says something about a minor. Keep form answers, bookings and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place, language settings and search terms, should not be aimed at minors, and should not be built from a list of patients or people who were screened.

Tone and patient stories

People may put off screening because of past pain, trauma, embarrassment or worry about the result, and parents may hesitate about the HPV vaccine because the virus spreads through sexual contact. Lead with what the test checks and how it is done, say the person can ask questions, stop the exam or bring someone with them, and keep fear out of it: no photos of illness, no countdowns, no wording that suggests a person who missed screening is to blame. On vaccine pages, talk about cancer prevention in the CDC’s words, not about a child’s behavior. Use person-first words, and include transgender men and nonbinary people who have a cervix by saying “people with a cervix” where the source allows, while keeping the source’s own wording when you quote it.

A story from a person who came back for screening after years away, or a parent who chose the vaccine, is a strong message for outreach. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. Pair the story with the attributed federal statement, say results differ, and get a signed authorization under 45 CFR 164.508 where the practice is a covered entity. A story should not show a minor without a parent’s written consent, should not name a result or a diagnosis unless the person chose to share it in writing, and should name no test brand or vaccine brand; say if the person received anything for taking part, and let them review the final version. Our guides to patient photo consent and testimonials and before and after photos cover the full rules.

Illustration: two screening outreach messages

Illustration: a flyer reads “Every woman needs a Pap every year. Skip it and you could have cancer and not know it. New: test yourself at home, no exam ever again. Had the HPV shot? You’re covered for life and can skip screening. One shot is all your child needs. Free screening and a free gift card for everyone!” It gives one interval for everyone, uses fear, overstates self-collection, tells vaccinated people to skip screening, gives a dose count the court case has put in doubt, and offers a gift card without counsel’s review.

Illustration: a second flyer for the same practice reads “Cervical cancer screening checks for changes before they become cancer. Federal recommendations call for screening from age 21 to 65 at intervals of 3 or 5 years, depending on your age and the test. At [Practice name], a clinician helps you choose the test, and for some people aged 30 to 65 we offer a swab you take yourself in our office. We call you with results within [days] and explain what they mean. Had the HPV vaccine? You still need screening. Bleeding that is not normal for you? Call [phone] for a visit, do not wait for screening. Call 911 for an emergency. Call [phone] during [days and hours] to book.” It names the federal range, leaves the choice to the clinician, describes self-collection as the practice offers it, keeps vaccinated people screening and puts the symptom and emergency lines first.

Checklist before a cervical cancer screening or HPV vaccine campaign goes live

• Screening copy built on the USPSTF 2018 recommendation and the HRSA December 2025 update, each named and dated next to its own intervals, with both sites checked for an update at each review.
• No single interval for everyone; the clinician confirms the test and interval for each person; groups the USPSTF recommends against screening not targeted.
• Self-collection described only as the approved labeling of the practice’s test allows, in the clinic or at home, with the follow-up a positive result may need.
• Results described by type in the words CDC uses; no result posted, texted or left on voicemail; the next step for an abnormal or positive result named.
• HPV vaccine pages that quote CDC age groups and side effect wording with dates; no dose count for children until the current CDC schedule and the court case have been checked; no brand names; no school requirement claim unless checked.
• Every vaccine page says vaccinated people still need screening.
• The symptom line and the 911 line on pages, flyers, event cards, voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools, reviewed by the practice’s clinicians.
• Recall texts, postcards, caller ID names and voicemails name no test, result, body part or vaccine; teen reminders go to the contact the family chose; opt-outs honored.
• Medicare coverage described as Medicare.gov states it; the CDC early detection program linked, not promised; coverage checked per patient; no “free follow-up care” unless confirmed.
• Free screening days, free doses, gift cards and raffles reviewed by counsel under 16 CFR 251.1 and 42 U.S.C. 1320a-7a(a)(5), and against grant terms.
• No free staff, doses or funding from vaccine makers, test makers or labs tied to orders, and no per-person payments to schools, partners or venues, without counsel’s review.
• Form answers, bookings and patient lists stay out of pixels and ad audiences; no ads aimed at minors; stories have signed authorizations and say results differ.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including primary care, women’s health, pediatric, community health and sexual health practices. For a cervical cancer screening and HPV vaccine program, that means a site that builds its screening page on the USPSTF and HRSA recommendations as written and dated, describes self-collection as the practice’s test allows, explains results and the vaccine in the words CDC uses, puts the symptom and 911 lines above the booking button, and answers “pap smear near me” and “hpv vaccine age” searches without a promise, plus appointment request pages that keep answers off the web and away from tracking tools. Our front desk tools hand symptoms to a clinician or the on-call line, emergencies to the 911 line, and questions about results to a clinician, and do not explain test results. We do not decide who needs screening, which test or which vaccine dose; your clinicians do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• USPSTF: Cervical Cancer: Screening (final recommendation, August 21, 2018; update in progress)
• HRSA: Women’s Preventive Services Guidelines (last reviewed December 2025)
• CDC: Screening for Cervical Cancer (February 26, 2025)
• CDC: HPV Vaccine (August 20, 2024)
• CDC: HPV Vaccination Considerations (July 9, 2024)
• CDC: Child and Adolescent Immunization Schedule Notes (2025 schedule, updated July 1, 2025)
• CDC: Adult Immunization Schedule Notes (2025 schedule, addendum updated July 2, 2025)
• Congressional Research Service: The 2026 Childhood Immunization Schedule (June 11, 2026)
• Congressional Research Service: CDC’s Updated Childhood Vaccine Schedule: Litigation and Potential Implications for Vaccine Injury Compensation Program (May 4, 2026)
• National Cancer Institute: Cervical Cancer Screening (updated February 13, 2025)
• MedlinePlus: Cervical Cancer (last updated January 2, 2025)
• FDA: FDA Roundup, May 17, 2024 (content current as of May 17, 2024)
• FDA: Premarket Approval (PMA) database (checked October 30, 2026)
• Medicare.gov: Cervical and vaginal cancer screenings (checked October 30, 2026)
• 45 CFR 164.501: Definitions
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• FDA: Questions and Answers on Dietary Supplements (content current as of August 27, 2026)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7a: Civil monetary penalties
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing